Anna Hung | Scholars@Duke

Anna Hung
Instructor in the Department of Population Health Sciences

Anna Hung, PharmD, PhD, MS is a pharmacist and health services researcher interested in payer and patient decision making related to pharmacy benefits. For her dissertation, she collaborated with the Defense Health Agency to evaluate the budgetary impact of their antidiabetic drug formulary changes. She has also worked with a variety of managed care organizations to assess their drug utilization and clinical management programs. Her methodological research interests include health care cost evaluations, quasi-experimental study designs, and stated preference research.

Dr. Hung received her Doctor of Pharmacy, Master of Science, and Doctor of Philosophy from the University of Maryland. Her PhD is in pharmaceutical health services research, with concentrations in pharmacoeconomics, comparative effectiveness research, and patient-centered outcomes research. Prior to joining the Department of Population Health Sciences, she completed a post-doctoral fellowship at the Duke Clinical Research Institute and served as Co-Chief Fellow.

Current Appointments & Affiliations

Instructor in the Department of Population Health Sciences, Population Health Sciences, Basic Science Departments 2020

Contact Information

200 Morris Street, 7th Floor, Durham, NC 27701
anna.hung@duke.edu (919) 668-1493

Background
Education, Training, & Certifications
- Ph.D., University of Maryland, Baltimore 2018
- M.S., University of Maryland, Baltimore 2016
- Pharm.D., University of Maryland, Baltimore 2014
- B.S., University of Maryland, College Park 2010
Expertise
Subject Headings
- Health Services Research
Research
Selected Grants
- Changes in Weight and Physical Function for Older African American Women in National, Peer-Led, Community-Based Weight Loss Program awarded by National Institutes of Health 2019 - 2024
- VA IPA for Anna Hung awarded by Durham Veterans Affairs Medical Center 2019 - 2021
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Goodlett, Dana, Anna Hung, Ashley Feriozzi, Hien Lu, Justin E. Bekelman, and C Daniel Mullins. “Site engagement for multi-site clinical trials.” Contemp Clin Trials Commun 19 (September 2020): 100608. https://doi.org/10.1016/j.conctc.2020.100608.
    Full Text Link to Item
  - Olsen, Maren K., Karen M. Stechuchak, Anna Hung, Eugene Z. Oddone, Laura J. Damschroder, David Edelman, and Matthew L. Maciejewski. “A data-driven examination of which patients follow trial protocol.” Contemp Clin Trials Commun 19 (September 2020): 100631. https://doi.org/10.1016/j.conctc.2020.100631.
    Full Text Link to Item
  - Hung, Anna, Monika Schneider, Marianne Hamilton Lopez, and Mark McClellan. “Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials.” J Manag Care Spec Pharm 26, no. 7 (July 2020): 888–900. https://doi.org/10.18553/jmcp.2020.26.7.888.
    Full Text Link to Item
  - Maciejewski, Matthew L., and Anna Hung. “High-Deductible Health Plans and Health Savings Accounts: A Match Made in Heaven but Not for This Irrational World.” Jama Network Open 3, no. 7 (July 2020): e2011000. https://doi.org/10.1001/jamanetworkopen.2020.11000.
    Full Text
  - Hung, Anna, Bhavna Jois, Amy Lugo, and Julia F. Slejko. “Cost-effectiveness of diabetes treatment sequences to inform step therapy policies.” Am J Manag Care 26, no. 3 (March 1, 2020): e76–83. https://doi.org/10.37765/ajmc.2020.42639.
    Full Text Link to Item
  - Hung, Anna, Christopher Bush, Melissa Greiner, Hilary Campbell, Bradley Hammill, Matthew L. Maciejewski, and Aaron McKethan. “Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.” J Manag Care Spec Pharm 26, no. 2 (February 2020): 169–75. https://doi.org/10.18553/jmcp.2020.26.2.169.
    Full Text Link to Item
  - Hung, A., Y. Li, F. J. Keefe, D. C. Ang, J. Slover, R. A. Perera, L. Dumenci, S. D. Reed, and D. L. Riddle. “Ninety-day and one-year healthcare utilization and costs after knee arthroplasty.” Osteoarthritis Cartilage 27, no. 10 (October 2019): 1462–69. https://doi.org/10.1016/j.joca.2019.05.019.
    Full Text Link to Item
  - Hung, Anna, Amy Lugo, and C Daniel Mullins. “Modeling the Budgetary Impact of Payer Utilization Management Strategies: An Adapted Framework Based on Lessons Learned.” J Manag Care Spec Pharm 25, no. 8 (August 2019): 922–26. https://doi.org/10.18553/jmcp.2019.25.8.922.
    Full Text Link to Item
  - Hung, Anna, Julia F. Slejko, Amy Lugo, Fadia Shaya, Stuart T. Haines, and C Daniel Mullins. “Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study.” J Manag Care Spec Pharm 25, no. 8 (August 2019): 913–21. https://doi.org/10.18553/jmcp.2019.25.8.913.
    Full Text Link to Item
  - Hung, Anna, Rodney Gedey, Marti Groeneweg, and Michelle Jay. “A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data.” J Manag Care Spec Pharm 25, no. 5 (May 2019): 538–43. https://doi.org/10.18553/jmcp.2019.25.5.538.
    Full Text Link to Item
  - Doshi, Peter, Jan Sieluk, and Anna Hung. “The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?” J Am Pharm Assoc (2003) 59, no. 2 (March 2019): 195–201. https://doi.org/10.1016/j.japh.2018.12.003.
    Full Text Link to Item
  - Hung, Anna, C Daniel Mullins, Julia F. Slejko, Stuart T. Haines, Fadia Shaya, and Amy Lugo. “Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.” J Manag Care Spec Pharm 25, no. 3 (March 2019): 342–49. https://doi.org/10.18553/jmcp.2019.25.3.342.
    Full Text Link to Item
  - Hung, Anna, Quyen Vu, and Lisa Mostovoy. “A Systematic Review of U.S. Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding?” J Manag Care Spec Pharm 23, no. 12 (December 2017): 1234–44. https://doi.org/10.18553/jmcp.2017.23.12.1234.
    Full Text Link to Item
  - Hung, Anna, and Eleanor M. Perfetto. “What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?” J Manag Care Spec Pharm 22, no. 7 (July 2016): 773–78. https://doi.org/10.18553/jmcp.2016.22.7.773.
    Full Text Link to Item
  - Bikov, Kaloyan A., C Daniel Mullins, Anna Hung, Brian Seal, Eberechukwu Onukwugha, and Nader Hanna. “Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer.” Oncologist 21, no. 6 (June 2016): 676–83. https://doi.org/10.1634/theoncologist.2015-0199.
    Full Text Link to Item
  - Hung, Anna, Bruce Stuart, and Ilene Harris. “The effect of Medicare Advantage enrollment on mammographic screening.” Am J Manag Care 22, no. 2 (February 1, 2016): e53–59.
    Link to Item
  - Hung, Anna, Jan Sieluk, and Peter Doshi. “The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.” Jama Intern Med 176, no. 1 (January 2016): 11–12. https://doi.org/10.1001/jamainternmed.2015.6656.
    Full Text Link to Item
  - Hung, Anna, and Françoise Pradel. “A review of how the quality of HIV clinical services has been evaluated or improved.” Int J Std Aids 26, no. 7 (June 2015): 445–55. https://doi.org/10.1177/0956462414543938.
    Full Text Link to Item
  - Desai, Bansri, Erin Freeman, Ellen Huang, Anna Hung, Edward Knapp, Ian M. Breunig, Mary L. McPherson, and Fadia T. Shaya. “Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.” Expert Rev Clin Pharmacol 7, no. 2 (March 2014): 203–9. https://doi.org/10.1586/17512433.2014.889562.
    Full Text Link to Item
  - Hung, Anna, and C Daniel Mullins. “Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review.” Oncologist 18, no. 1 (2013): 54–63. https://doi.org/10.1634/theoncologist.2012-0050.
    Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Subject Headings

Selected Grants

Selected Publications

Academic Articles